By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biomedical Advanced Research and Development Authority (BARDA) 

330 C Street, SW
Room G640
Washington  D.C.  20201  U.S.A.
Phone: 202-260-1200 Fax: 202-205-4520



Company News
BARDA Awards IDT Biologika Contract For Live Virus Filling And Finishing Services 10/24/2016 8:54:52 AM
BARDA Awards $37.6 Million Contract To Sanofi Genzyme (SNY) To Supply Leukine (Sargramostim) For Potential Public Health Emergency 10/7/2016 11:27:58 AM
NewLink Genetics (NLNK) Awarded $25 Million Contract From BARDA A For Investigational Ebola Zaire Vaccine (V920) 10/5/2016 7:50:06 AM
DxTerity Awarded Up To $150 Million BARDA Contract For Advanced Development And Delivery Of REDI-Dx High Throughput Radiation Biodosimetry Test 10/5/2016 6:43:23 AM
DNAe Wins $51.9 Million BARDA Contract to Develop Semiconductor DNA Sequencing Platform for Rapid Diagnosis of Antimicrobial Resistant Infections and Influenza 9/30/2016 7:46:30 AM
BARDA Increases Contract Option With Cytori (CYTX) To Advance Countermeasure Clinical Trial 9/19/2016 10:11:41 AM
Moderna Announces Funding Award From BARDA For $8 Million With Potential Of Up To $125 Million To Accelerate Development Of Zika Messenger RNA (mRNA) Vaccine 9/7/2016 11:33:20 AM
BARDA Awards Protein Sciences Corporation Multi-Million Dollar Contract For Pandemic Preparedness 9/7/2016 9:24:45 AM
SAb Biotherapeutics Announces Contract With BARDA To Advance First MERS Treatment 8/24/2016 10:52:50 AM
Regeneron (REGN) Announces Agreement With BARDA For The Manufacturing And Testing Of New Antibodies Against MERS Virus 8/22/2016 6:52:40 AM